ATE465412T1 - Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen - Google Patents

Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen

Info

Publication number
ATE465412T1
ATE465412T1 AT04818645T AT04818645T ATE465412T1 AT E465412 T1 ATE465412 T1 AT E465412T1 AT 04818645 T AT04818645 T AT 04818645T AT 04818645 T AT04818645 T AT 04818645T AT E465412 T1 ATE465412 T1 AT E465412T1
Authority
AT
Austria
Prior art keywords
epilepsy
immunosorb
assessing
blood tests
paroxysmal cerebral
Prior art date
Application number
AT04818645T
Other languages
English (en)
Inventor
Svetlana Dambinova
Galina Izykenova
Original Assignee
Grace Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grace Lab Inc filed Critical Grace Lab Inc
Application granted granted Critical
Publication of ATE465412T1 publication Critical patent/ATE465412T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2857—Seizure disorders; Epilepsy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04818645T 2003-11-06 2004-11-08 Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen ATE465412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51767103P 2003-11-06 2003-11-06
PCT/US2004/037088 WO2005046442A2 (en) 2003-11-06 2004-11-08 Immunosorbent tests for assessing paroxysmal cerebral discharges

Publications (1)

Publication Number Publication Date
ATE465412T1 true ATE465412T1 (de) 2010-05-15

Family

ID=34590180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818645T ATE465412T1 (de) 2003-11-06 2004-11-08 Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen

Country Status (10)

Country Link
US (1) US7820398B2 (de)
EP (1) EP1689288B1 (de)
JP (1) JP4838140B2 (de)
CN (1) CN1954211A (de)
AT (1) ATE465412T1 (de)
AU (1) AU2004288717A1 (de)
CA (1) CA2585876A1 (de)
DE (1) DE602004026767D1 (de)
EA (1) EA200600920A1 (de)
WO (1) WO2005046442A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20060257943A1 (en) * 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
US20060281135A1 (en) * 2005-06-13 2006-12-14 Cis Biotech, Inc. Methods for diagnosing and treating cerebrovascular events based on NR2 peptides
US8536115B2 (en) 2006-08-31 2013-09-17 Centre For Addiction And Mental Health Compositions and methods for modulating AMPA receptor-mediated excitotoxicity
WO2013102264A1 (en) * 2012-01-04 2013-07-11 Centre For Addiction And Mental Health Compositions and methods for modulating ampa receptor-mediated excitotoxicity
US10610861B2 (en) 2012-12-17 2020-04-07 Accellix Ltd. Systems, compositions and methods for detecting a biological condition
EP2932268A4 (de) 2012-12-17 2016-10-19 Leukodx Ltd Systeme und verfahren zum erkennen eines biologischen zustands
US9759722B2 (en) * 2012-12-17 2017-09-12 Leukodx Ltd. Systems and methods for determining a chemical state
EP2863231A1 (de) * 2013-10-17 2015-04-22 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnostisches Verfahren zum Nachweis einer GABA(A)-verwandten Autoimmunerkrankung und zugehörige Subjektmaterie
US9958521B2 (en) 2015-07-07 2018-05-01 Q Bio, Inc. Field-invariant quantitative magnetic-resonance signatures
US10194829B2 (en) 2015-07-07 2019-02-05 Q Bio, Inc. Fast scanning based on magnetic resonance history
US9665734B2 (en) 2015-09-12 2017-05-30 Q Bio, Inc. Uniform-frequency records with obscured context
US10964412B2 (en) 2015-10-20 2021-03-30 Q Bio, Inc. Population-based medical rules via anonymous sharing
US10359486B2 (en) 2016-04-03 2019-07-23 Q Bio, Inc. Rapid determination of a relaxation time
US10222441B2 (en) 2016-04-03 2019-03-05 Q Bio, Inc. Tensor field mapping
WO2018144044A1 (en) * 2017-02-03 2018-08-09 Q Bio, Inc. lTERATIVE MEDICAL TESTING OF BIOLOGICAL SAMPLES
US11650195B2 (en) 2017-02-03 2023-05-16 Q Bio, Inc. Iterative medical testing of biological samples
US10936180B2 (en) 2017-03-16 2021-03-02 Q Bio, Inc. User interface for medical information
US11360166B2 (en) 2019-02-15 2022-06-14 Q Bio, Inc Tensor field mapping with magnetostatic constraint
US11354586B2 (en) 2019-02-15 2022-06-07 Q Bio, Inc. Model parameter determination using a predictive model
US20220196637A1 (en) 2019-05-24 2022-06-23 Fujirebio Inc. Method and reagent for measuring thyroglobulin
JP7494199B2 (ja) 2019-09-27 2024-06-03 富士レビオ株式会社 Ｂ型肝炎ウイルスコア関連抗原のイムノアッセイ及びそのためのキット
US11614509B2 (en) 2019-09-27 2023-03-28 Q Bio, Inc. Maxwell parallel imaging
KR102622283B1 (ko) 2019-09-27 2024-01-08 큐 바이오, 인코퍼레이티드 맥스웰 병렬 이미징
JPWO2021200940A1 (de) 2020-03-31 2021-10-07
WO2023013725A1 (ja) 2021-08-06 2023-02-09 株式会社先端生命科学研究所 サイログロブリンのイムノアッセイ及びそのためのキット
US11614508B1 (en) 2021-10-25 2023-03-28 Q Bio, Inc. Sparse representation of measurements

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures
JP3149133B2 (ja) * 1989-10-27 2001-03-26 ザ ソーク インスティチュート フォア バイオロジカル スタディーズ グルタメート受容体組成物および方法
EP0558747B1 (de) 1991-06-26 1998-01-07 Obschestvo S Ogranichennoi Otvetstvennostju " Dies" Immunadsorbens zur diagnose von epilepsie und der risikogruppe
JP2782695B2 (ja) 1992-09-11 1998-08-06 ダムビノヴァ，スヴェトラーナ・アレクサンドロフナ 神経症および精神病の診断用免疫吸着剤およびその実際的用途
RU2112243C1 (ru) 1995-11-29 1998-05-27 Светлана Александровна Дамбинова Набор "па-тест" для диагностики неврологических заболеваний
US6896872B2 (en) 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
US20050233390A1 (en) * 2003-04-09 2005-10-20 Allen John W Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor
US20060257943A1 (en) 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery

Also Published As

Publication number Publication date
US7820398B2 (en) 2010-10-26
AU2004288717A1 (en) 2005-05-26
CN1954211A (zh) 2007-04-25
AU2004288717A2 (en) 2005-05-26
DE602004026767D1 (de) 2010-06-02
EA200600920A1 (ru) 2007-04-27
JP4838140B2 (ja) 2011-12-14
WO2005046442A2 (en) 2005-05-26
EP1689288B1 (de) 2010-04-21
EP1689288A2 (de) 2006-08-16
JP2007517188A (ja) 2007-06-28
CA2585876A1 (en) 2005-05-26
WO2005046442A3 (en) 2006-12-07
EP1689288A4 (de) 2007-09-26
US20050181466A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
ATE465412T1 (de) Immunsorbens-bluttests zur beurteilung von paroxysmalen zerebralentladungen
Sammler et al. Prosody meets syntax: the role of the corpus callosum
Gallagher et al. Ageing: the cholinergic hypothesis of cognitive decline
Bruehl et al. The relationship between pain sensitivity and blood pressure in normotensives
Jannati et al. Test–retest reliability of the effects of continuous theta-burst stimulation
Sarto et al. Effects of short‐term unloading and active recovery on human motor unit properties, neuromuscular junction transmission and transcriptomic profile
Gillivan-Murphy et al. Voice tremor in Parkinson's disease: an acoustic study
DE602005000874D1 (de) Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke
Colzato et al. RETRACTED ARTICLE: The effect of gamma-enhancing binaural beats on the control of feature bindings
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
Basuta et al. High functioning male with fragile X syndrome and fragile X‐associated tremor/ataxia syndrome
Fostick et al. Temporal and non-temporal processes in the elderly
DE60329020D1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel des analyten für die extrazelluläre domäne (ecd) des epidermalen wachstumsfaktor-rezeptors (egfr), allein oder in kombination mit anderen analyten, in proben von körperflüssigkeiten
Tacik et al. Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1
Jannati et al. Modulation of motor cortical excitability by continuous theta-burst stimulation in adults with autism spectrum disorder
Wang et al. 40-Hz optogenetic stimulation rescues functional synaptic plasticity after stroke
Bonin-Guillaume et al. An additive factor analysis of the effect of depression on the reaction time of old patients
Gaede et al. Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers
de Toledo Gonçalves et al. OPRM1 and BDNF polymorphisms associated with a compensatory neurophysiologic signature in knee osteoarthritis patients
Brown et al. Electroencephalography in young onset dementia
Gupta et al. Effect of antiepileptic drugs on psychomotor functions and memory in epilepsy patients
Jarkiewicz et al. Can new paradigms bring new perspectives for mismatch negativity studies in schizophrenia?
Safi et al. Recruitment of the left precentral gyrus in reading epilepsy: a multimodal neuroimaging study
Reinhart et al. Assessing neglect dyslexia with compound words.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties